GlassScriptPhysician profile
Peter R Carroll
NPI 1366461667
$29,800.45
in general payments reported to CMS, 2019-2025
9 companies · $3,330 in 2025
The $3,330 reported for 2025 was more than what 88% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18K · 2020: $6,276 · 2023: $94.58 · 2024: $2,187 · 2025: $3,330.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,108 · Education: $2,100 · Food and Beverage: $309 · Gift: $94.58.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,107.50 |
| Education | $2,099.99 |
| Food and Beverage | $309.40 |
| Gift | $94.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Chugai Pharmaceutical Co., LTD. | $12,198.73 | 2019 | |
| Insightec,INC | $8,274.13 | 2019-2020 | |
| Intuitive Surgical, INC. | $2,753.76 | 2019-2025 | Da Vinci Surgical System |
| Progenics Pharmaceuticals, INC. | $2,250.00 | 2020 | |
| Janssen Scientific Affairs, LLC | $2,027.84 | 2024 | Erleada |
| Tolmar, INC. | $1,200.00 | 2025 | |
| Insightec,LTD | $966.28 | 2019 | |
| Janssen Biotech, INC. | $99.99 | 2025 | Erleada |
| Koelis INC. | $29.72 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Carroll listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.